Analyst Reco. Cipla Limited

Equities

CIPLA

INE059A01026

Market Closed - NSE India S.E. Other stock markets 05:17:53 21/06/2024 pm IST			5-day change	1st Jan Change
1,542 ^INR	-0.21%		-1.48%	+23.69%

21/06	Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India	RE
18/06	Cipla to Invest Additional 3 Million Euros in Germany's Ethris	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Nomura Adjusts Cipla’s Price Target to INR1,535 From INR1,486, Keeps at Neutral	23/05	MT
Nomura Adjusts Cipla’s Price Target to INR1,486 From INR1,569, Keeps at Neutral	14/05	MT
Jefferies Adjusts Cipla’s Price Target to INR1,400 From INR1,250, Keeps at Hold	13/05	MT
Nomura Downgrades Cipla to Neutral From Buy, Price Target to INR1,427 From INR1,353	30/01	MT
Jefferies Adjusts Cipla’s Price Target to INR1,250 From INR1,210, Keeps at Hold	29/01	MT
Nomura Adjusts Cipla's Price Target to INR1,353 from INR1,229, Keeps at Buy	30/23/30	MT
Jefferies Downgrades Cipla to Hold From Buy, Adjusts Price Target to INR1,230 From INR1,210	30/23/30	MT
Nomura Adjusts Cipla's Price Target to INR1,229 From INR1,036, Keeps at Buy	28/23/28	MT
Jefferies Upgrades Cipla’s Price Target to Buy From Hold, Adjusts Price Target to INR1,210 from INR900	27/23/27	MT
INDIA STOCKS-Indian shares set to open higher as US data ups smaller rate hikes bets	15/23/15	RE
Nomura Adjusts Cipla's Price Target to INR1,036 From INR1,195, Keeps at Buy	09/23/09	MT
Jefferies Adjusts Cipla’s Price Target to INR900 From INR1,100, Keeps at Hold	08/23/08	MT
INDIA STOCKS-Indian shares muted on U.S. rate hike worries, pharma stocks slide	20/23/20	RE
INDIA STOCKS-Indian shares off to a muted start on U.S. rate hike worries, pharma stocks slide	20/23/20	RE
Indian Indices End on Positive Note Following US Fed's Interest Rate Increase; Housing Development Finance Jumps 5%	17/22/17	MT
Nomura Adjusts Cipla's Price Target to 1,195 Indian Rupees From 1,051 Indian Rupes, Keeps at Buy	28/22/28	MT
CIPLA : Nomura Adjusts Cipla's Price Target to 1,051 Indian Rupees From 861 Indian Rupees, Keeps at Buy	18/21/18	MT
SENSEX 30 : Indian Indices Witness Strong Buying; Punjab National Bank Drops 6%	16/20/16	MT
Cipla Limited Announces the Launch of Daptomycin for Injection, 500mg/vial, Single-Dose Vial, AP-Rated Generic Equivalent of Cubicin for Injection in the United States	25/19/25	CI
Cipla Limited Reports Unaudited Consolidated and Standalone Earnings Results for the First Quarter Ended June 30, 2018: Provides Tax Rate Guidance for the Fiscal Year 2019	08/18/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Cipla Limited

Equities

CIPLA

INE059A01026

Analyst Reco.

Filters